Low Dose Radiotherapy to Boost Immune Response in Pancreatic Cancer
Author Information
Author(s): Timke Carmen, Winnenthal Hubertus Schmitz, Klug Felix, Roeder Falk FF, Bonertz Andreas, Reissfelder Christoph, Rochet Nathalie, Koch Moritz, Tjaden Christine, Buechler Markus W, Debus Juergen, Werner Jens, Beckhove Philipp, Weitz Jürgen, Huber Peter E
Primary Institution: German Cancer Research Center and University Hospital Center, Heidelberg, Germany
Hypothesis
Can low dose single fraction radiotherapy improve T cell associated antitumor immune response in patients with pancreatic cancer?
Conclusion
The study aims to determine if low dose radiotherapy can increase tumor infiltrating T cells and enhance the immune response against pancreatic cancer.
Supporting Evidence
- Radiation can modify the tumor microenvironment and generate inflammation.
- Low dose radiation may enhance the migration and activation of T cells.
- Previous studies suggest that ionizing radiation can stimulate immune responses.
- Patients with higher tumor infiltrating T cells have better prognoses.
Takeaway
This study is trying to see if giving a small amount of radiation before surgery can help the body's immune system fight pancreatic cancer better.
Methodology
This is a randomized controlled phase I/II trial with 40 patients receiving different doses of radiation before surgery.
Potential Biases
Potential bias in patient selection and randomization process.
Limitations
The study may not account for all confounding factors affecting immune response.
Participant Demographics
Patients with resectable pancreatic cancer, aged over 50.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website